ESC 365 - Validation of cardiac magnetic resonance T1 mapping in cardiac amyloidosis

ESC Premium Access

Validation of cardiac magnetic resonance T1 mapping in cardiac amyloidosis

Session: CMR tissue characterisation in myocardial disease

Topic: Cardiovascular Magnetic Resonance (CMR)

Speaker: Doctor F. Duca (Vienna, AT)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Franz Duca

Medical University of Vienna, Vienna (Austria)

2 presentations

0 follower

9 more presentations in this session

MRI prospective survey on heart and liver iron and cardiac function in thalassemia major patients treated with Deferasirox versus Deferiprone and Desferrioxamine in monotherapy

Speaker: Doctor A. Pepe (Pisa, IT)

Longitudinal prospective CMR study in pediatric thalassemia major patients

Speaker: Doctor A. Pepe (Pisa, IT)

Cardiac manifestation in wilson disease. The CARMA Wilson study. A comprehensive clinical and cardiac imaging trial

Speaker: Doctor S. Quick (Chemnitz, DE)

Congenital hypertrophic cardiomyopathy with genetic mutations is highly associated with left ventricular myocardial fibrosis and larger right ventricle (TW-HCM study)

Speaker: Doctor C. Chen (Taipei, TW)

Long term prognostic value of Cardiac Magnetic Resonance parameters in left ventricular non-compaction

Speaker: Doctor A. Pepe (Pisa, IT)

Access the full session

CMR tissue characterisation in myocardial disease

Speakers: Doctor F. Duca, Doctor A. Pepe, Doctor A. Pepe, Doctor S. Quick, Doctor C. Chen...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources